Vismodegib (Erivedge) for basal cell carcinoma

MeSH terms

• Administration, Oral
• Anilides / adverse effects
• Anilides / pharmacology
• Anilides / therapeutic use*
• Animals
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• Carcinoma, Basal Cell / drug therapy*
• Carcinoma, Basal Cell / pathology
• Drug Approval
• Hedgehog Proteins / antagonists & inhibitors
• Humans
• Pyridines / adverse effects
• Pyridines / pharmacology
• Pyridines / therapeutic use*
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• United States
• United States Food and Drug Administration